First Allied Advisory Services’s Dr. Reddy's Laboratories RDY Stock Holding History

First Allied Advisory Services’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-47,355	Closed	-$541K	–	1174
2015 Q1	$541K	Sell	47,355 -3,405	-7%	-$36.1K	0.04%	551
2014 Q4	$518K	Sell	50,760 -1,330	-3%	-$14K	0.04%	518
2014 Q3	$548K	Buy	+52,090	New	+$490K	0.04%	482

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CCM

Causeway Capital Management Los Angeles, California $9.24B AUM 21.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

First Allied Advisory Services's RDY Position: Q2 2015 in Review

First Allied Advisory Services sold out of Dr. Reddy's Laboratories (RDY) in Q2 2015, closing a stake of 47,355 shares — an estimated $541K sold.

First Allied Advisory Services first reported a position in RDY in Q3 2014 and held it in 3 quarters. The position peaked at $548K in Q3 2014. 190 funds tracked by Wall St. Rank hold RDY as of Q2 2015.

First Allied Advisory Services reported no remaining Dr. Reddy's Laboratories position as of Q2 2015 after selling out during the quarter.
First Allied Advisory Services sold 47,355 Dr. Reddy's Laboratories shares in Q2 2015, an estimated $541K.
First Allied Advisory Services first reported a position in Dr. Reddy's Laboratories in Q3 2014 and held it in 3 quarters.
First Allied Advisory Services's Dr. Reddy's Laboratories position peaked at $548K in Q3 2014.
190 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2015.

Based on First Allied Advisory Services's 13F filing for Q2 2015, filed 13 Aug 2015.